Conference Preview 2022 CSCO Annual Conference Harbin Branch &The 7th Anti-Leukemia and Lymphoma International Summit Forum invites you to attend (November 10-11)

In recent years, China has made significant progress in the field of leukemia and lymphoma, with the continuous emergence of new drugs and new therapies such as targeted therapy drugs and cellular immunotherapy, a large number of basic and clinical research results have emerged, and the diagnosis and treatment level of leukemia and lymphoma has been greatly improved, but there is still a big gap
compared with European and American countries.

In order to further improve the diagnosis and treatment level of leukemia and lymphoma in China, Harbin Hematological Diseases is sponsored by the Chinese Society of Clinical Oncology (CSCO), CSCO Leukemia Expert Committee and CSCO Lymphoma Expert Committee The "25th National Congress of Clinical Oncology 2022 CSCO Academic Annual Conference Harbin Branch, the 10th CSCO Leukemia &Lymphoma Expert Committee Academic Conference, the 7th Anti-Leukemia &Lymphoma International Summit Forum and CSCO Leukemia & Lymphoma Expert Committee Tour - Harbin Station" hosted by the Cancer Institute and Peking University Cancer Hospital will be held in Harbin on November 10-11, online and offline simultaneously, you are invited to participate together!

Gathering of heroes and highlights

9 academic sessions are presented one by one

In this conference, a number of academic sessions such as academician forum, leukemia and lymphoma session, lymphoma youth forum, leukemia youth forum, children's blood special session, tumor-related anemia forum and other academic special sessions were set up, and famous experts and scholars in the field of hematological oncology at home and abroad were specially invited to discuss basic research, cutting-edge progress and hot topics
in the fields of leukemia, lymphoma, myeloma and myelodysplastic syndrome (MDS) at home and abroad.

Academician Forum and Leukemia and Lymphoma

Stay tuned

This conference invited 5 academicians to give academic reports
in the fields of leukemia, lymphoma, innovative drugs and basic research.
There are a total of 3 leukemia and lymphoma sessions, including immune checkpoint inhibitors, ADC drugs, BTK inhibitors, monoclonal antibodies and other cutting-edge advances in many popular fields, covering Chinese lymphoma big data analysis, WHO lymphoma classification and other content
.

There are many highlights of the conference, and the Youth Forum deserves attention

As one of the highlights of this conference, the Youth Forum invited many young basic and clinical workers to share their experiences and experiences
in clinical diagnosis and treatment.
From leukemia to lymphoma, from hematopoietic stem cell transplantation to cellular immunotherapy, young scholars will tell us about the relevant progress
in the field of leukemia and lymphoma from different perspectives.

In addition, this conference is not limited to the progress of clinical diagnosis and treatment, but also focuses on clinical safety management, molecular biology marker research, and comprehensive management of patients in the new crown period
.
Don't miss out on the conference!

Agenda of the meeting

November 10

November 11

Corporate Satellite Meeting

Talents gather together to climb academic peaks

Looking forward to your online participation!